On November 27, 2024, BioVie filed Amendment No. 1 to its Form S-1 Registration Statement with the SEC. This amendment was made to correct a scrivener's error in Exhibit 5.1 regarding the aggregate total being registered. The amendment includes only the facing page, explanatory note, Item 16(a) of Part II, the signature page, and the corrected Exhibit 5.1. The rest of the Registration Statement remains unchanged. BioVie is classified as a non-accelerated filer and a smaller reporting company. The company has not elected to use the extended transition period for complying with new or revised financial accounting standards. The registration statement will become effective as determined by the SEC under Section 8(a) of the Securities Act of 1933.

On November 27, 2024, BioVie filed Amendment No. 1 to its Form S-1 Registration Statement with the SEC. This amendment was made to correct a scrivener's error in Exhibit 5.1 regarding the aggregate total being registered. The amendment includes only the facing page, explanatory note, Item 16(a) of Part II, the signature page, and the corrected Exhibit 5.1. The rest of the Registration Statement remains unchanged. BioVie is classified as a non-accelerated filer and a smaller reporting company. The company has not elected to use the extended transition period for complying with new or revised financial accounting standards. The registration statement will become effective as determined by the SEC under Section 8(a) of the Securities Act of 1933.